Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
71 CHF | -1.25% | -1.80% | +39.49% |
Apr. 26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
Apr. 25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Sales 2023 | 96.72M 104M 94.38M | Sales 2024 * | 262M 281M 256M | Capitalization | 1.17B 1.25B 1.14B |
---|---|---|---|---|---|
Net income 2023 | 1M 1.07M 976K | Net income 2024 * | 111M 119M 108M | EV / Sales 2023 | 8.6 x |
Net cash position 2023 | 48.44M 52.03M 47.26M | Net cash position 2024 * | 110M 118M 107M | EV / Sales 2024 * | 4.04 x |
P/E ratio 2023 |
771
x | P/E ratio 2024 * |
9.99
x | Employees | 319 |
Yield 2023 |
3.65% | Yield 2024 * |
2.89% | Free-Float | 44.49% |
Latest transcript on Cosmo Pharmaceuticals N.V.
1 day | -1.25% | ||
1 week | -1.80% | ||
Current month | -1.80% | ||
1 month | +0.14% | ||
3 months | +12.52% | ||
6 months | +90.60% | ||
Current year | +39.49% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 05-12-31 | |
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 16-05-31 |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David W Maris
BRD | Director/Board Member | 57 | 21-05-27 |
Founder | 69 | 96-12-31 | |
Director/Board Member | 64 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 0 M€ | -.--% | - | |
0.00% | 0 M€ | +3.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 71 | -1.25% | 8,539 |
24-05-07 | 71.9 | -0.83% | 13,332 |
24-05-06 | 72.5 | +0.42% | 14,718 |
24-05-03 | 72.2 | +0.84% | 11,784 |
24-05-02 | 71.6 | -0.97% | 10,802 |
Delayed Quote Swiss Exchange, May 08, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.49% | 1.25B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.70% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- COPN Stock